CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

LH's Capital Expenditures Growth by Quarter and Year

Laboratory Of America Holdings's Capital Expenditures results by quarter and year




LH Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 117.90 770.80 99.40 128.20
III Quarter September 103.50 0.00 77.20 92.60
II Quarter June 143.30 -288.00 98.50 85.20
I Quarter March 0.00 95.40 106.60 94.20
FY   364.70 578.20 381.70 400.20



LH Capital Expenditures fourth quarter 2022 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported drop in Capital Expenditures in the fourth quarter 2022 by -84.7% to $ 117.90 millions, from the same quarter in 2021.
The fall in the fourth quarter 2022 Laboratory Corporation Of America Holdings's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 155.3%.

Looking into fourth quarter 2022 results within Medical Laboratories industry 20 other companies have achieved higher Capital Expenditures growth. While Laboratory Corporation Of America Holdings' s Capital Expenditures meltdown of -84.7% ranks overall at the positon no. 1899 in the fourth quarter 2022.


LH Capital Expenditures ( Y/Y Growth %) 2022
 2021 2020 2019
IV Quarter December -84.7 % 675.45 % -22.46 % 4.91 %
III Quarter September - - -16.63 % -5.41 %
II Quarter June - - 15.61 % -2.29 %
I Quarter March - -10.51 % 13.16 % 29.93 %
FY   -36.92 % 51.48 % -4.62 % 5.37 %

Financial Statements
Laboratory Of America Holdings's fourth quarter 2022 Capital Expenditures $ 117.90 millions LH's Income Statement
Laboratory Of America Holdings's fourth quarter 2021 Capital Expenditures $ 770.80 millions Quarterly LH's Income Statement
New: More LH's historic Capital Expenditures Growth >>


LH Capital Expenditures (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
IV Quarter December 13.91 % - 28.76 % 38.44 %
III Quarter September -27.77 % - -21.62 % 8.69 %
II Quarter June - - -7.6 % -9.55 %
I Quarter March - -4.02 % -16.85 % -22.91 %
FY (Year on Year)   -36.92 % 51.48 % -4.62 % 5.37 %


Suppliers by LH Divisions >> Back to LH Growth rate Comparisons >>


Capital Expenditures fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #312
Overall #1899

Capital Expenditures Y/Y Growth Statistics
High Average Low
5200 % 155.3 % -95.33 %
(Sep. 30, 2010)   (Dec 31 2022)
Capital Expenditures fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #312
Overall #1899
Capital Expenditures Y/Y Growth Statistics
High Average Low
5200 % 155.3 % -95.33 %
(Sep. 30, 2010)   (Dec 31 2022)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Laboratory Of America Holdings's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
155.78 % 9.04 % -100 %
(June 30. 2011)  


LH's IV. Quarter Q/Q Capital Expenditures Comment
Laboratory Corporation Of America Holdings achieved in the IV. Quarter 2022 above company average sequential Capital Expenditures rise of 13.91%, to $ 117.90 millions, from $103.50 millions in the third quarter.
Medical Laboratories company is going from strength to strength, with recording above average increase, and also improving speed, Richard Lyons, Medical Laboratories industry advisor situated in Philadelphia said.

Within Medical Laboratories industry 6 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Laboratory Of America Holdings's Capital Expenditures growth quarter on quarter, overall rank is 756.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #139
Overall #756
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #139
Overall #756
Capital Expenditures Q/Q Growth Statistics
High Average Low
155.78 % 9.04 % -100 %
(June 30. 2011)  


LH's IV. Quarter Q/Q Capital Expenditures Comment
Laboratory Corporation Of America Holdings achieved in the IV. Quarter 2022 above company average sequential Capital Expenditures rise of 13.91%, to $ 117.90 millions, from $103.50 millions in the third quarter.
Laboratory Of America Holdings is going from strength to strength, not only claiming higher then average increase, but also increasing pace, Richard Lyons, Medical Laboratories industry advisor situated in Philadelphia added.

Within Medical Laboratories industry 6 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Laboratory Of America Holdings's Capital Expenditures growth quarter on quarter, overall rank is 756.


Laboratory Of America Holdings's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 21.50 $ 674.40 $ 453.10 $ 21.80 $ 460.40
Y / Y Capital Expenditures Growth (TTM) -95.33 % - - -94.12 % 20.62 %
Year on Year Capital Expenditures Growth Overall Ranking # 890 # 0 # 0 # 2988 # 705
Seqeuential Capital Expenditures Change (TTM) -96.81 % 48.84 % 1978.44 % -95.26 % -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 2474 # 233 # 12 # 3298 # 0

New: More LH's historic Capital Expenditures Growth >>



Cumulative Capital Expenditures growth Comment
Laboratory Of America Holdings showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Sep 30 2022. If the fiscal year would end in Dec 31 2022, Laboratory Of America Holdings's annual Capital Expenditures drop would be -95.33% year on year to $22 millions.

In the Healthcare sector 125 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 0 to 890.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
5200 %
140.01 %
-151.4 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 126
Overall # 890

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
5200 %
155.3 %
-95.33 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 453
S&P 500 # 2474
Cumulative Capital Expenditures growth Comment
Laboratory Of America Holdings showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Sep 30 2022. If the fiscal year would end in Dec 31 2022, Laboratory Of America Holdings's annual Capital Expenditures drop would be -95.33% year on year to $22 millions.

In the Healthcare sector 125 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 0 to 890.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
5200 %
140.01 %
-151.4 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 126
Overall # 890

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
5200 %
155.3 %
-95.33 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 453
S&P 500 # 2474




Other Capital Expenditures Growth
Medical Laboratories Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
LH's Capital Expenditures Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for LH's Competitors
Capital Expenditures Growth for Laboratory Of America Holdings's Suppliers
Capital Expenditures Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2022
Encompass Health Corporation-0.10%$ -0.099 millions
Abbott Laboratories-0.65%$ -0.651 millions
Qualigen Therapeutics Inc -0.69%$ -0.687 millions
Rxsight Inc -0.82%$ -0.822 millions
Cryoport inc -0.94%$ -0.936 millions
Acadia Healthcare Company Inc -0.94%$ -0.941 millions
Alnylam Pharmaceuticals Inc -1.15%$ -1.147 millions
Achilles Therapeutics Plc-1.60%$ -1.598 millions
Regeneron Pharmaceuticals Inc -1.74%$ -1.743 millions
Warby Parker Inc -1.93%$ -1.932 millions
Gsk Plc-2.47%$ -2.474 millions
Emergent Biosolutions Inc -2.78%$ -2.784 millions
Ligand Pharmaceuticals Incorporated-2.92%$ -2.916 millions
Community Health Systems Inc -2.96%$ -2.963 millions
Vir Biotechnology Inc -3.60%$ -3.604 millions
1life Healthcare Inc -4.08%$ -4.082 millions
Henry Schein Inc -4.32%$ -4.319 millions
Pharvaris N v -4.41%$ -4.411 millions
Tenet Healthcare Corp-4.61%$ -4.605 millions
Merck and Co Inc -4.88%$ -4.884 millions
Edwards Lifesciences Corporation-5.01%$ -5.011 millions
Veru Inc -5.51%$ -5.507 millions
Opko Health Inc -5.85%$ -5.854 millions
Cano Health Inc -5.97%$ -5.973 millions
Axogen inc -6.31%$ -6.311 millions
Si bone inc -6.48%$ -6.479 millions
Qilian International Holding Group Limited-6.71%$ -6.710 millions
Iqvia Holdings Inc -7.07%$ -7.065 millions
Teva Pharmaceutical Industries Limited-7.19%$ -7.190 millions
Twist Bioscience Corporation-7.50%$ -7.502 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com